FDA Requests Laid-Off Employees Back to Help with Tobacco Cases, Enforcement Capacity Severely Weakened

Apr.17.2025
FDA Requests Laid-Off Employees Back to Help with Tobacco Cases, Enforcement Capacity Severely Weakened
FDA staff cuts impact tobacco enforcement: HHS layoffs jeopardize fines on retailers, potentially hindering tobacco law enforcement.

Key points:

FDA Layoffs Affect Tobacco Enforcement: The US Department of Health and Human Services (HHS) laid off approximately 10,000 employees on April 1, including the department responsible for fining retailers for violations under the FDA. This move may result in a slowdown in tobacco enforcement efforts.

FDA has requested that some laid-off employees temporarily return to work to help with unfinished cases. About 20 employees have agreed to return until their official departure on June 2nd.

 

Weakened regulatory ability: Layoffs have weakened the FDA's ability to enforce penalties on non-compliant retailers, experts worry this may undermine the recent decline in tobacco use rates.

Fines Income Affected: The disbandment of the Civil Fines Office could impact FDA's fines income, leading to a reduction in federal revenue. This office is also a key tool in cracking down on the illegal distribution of e-cigarettes.

Reasons for HHS Staff Reduction: The Department of Health and Human Services stated that the layoffs are primarily focused on administrative and redundant positions. However, FDA officials believe that this move severely undermines tobacco enforcement capabilities and could lead to looser retailer behavior.


According to a report from POLITICO on April 14th, the U.S. Food and Drug Administration (FDA) has recently asked some tobacco enforcement agents who were previously laid off to temporarily return to work in order to address the halt in regulatory capacity caused by significant manpower reductions.

 

According to four federal health officials, the layoffs were carried out by the Secretary of the Department of Health and Human Services (HHS), Robert F. Kennedy Jr., on April 1st, resulting in the dismissal of around 10,000 employees, including those responsible for imposing civil fines on non-compliant retailers at the FDA. This department was previously able to handle over a hundred cases of illegal sales per week, focusing on punishing stores that sell cigarettes and e-cigarettes to minors.

 

Informed officials have stated that the recent layoffs have crippled the FDA's main enforcement tool against tobacco retailers, leading to a halt in related case processing. In order to maintain enforcement continuity as much as possible, senior FDA officials recently invited some laid-off employees to return on a short-term basis to assist with processing before their formal departure date on June 2nd. As of last Friday, more than 20 people have agreed to return to work. It is reported that some employees are concerned that if they refuse to return, they may lose their severance package.

 

Kennedy's cost-cutting measures have not affected the team responsible for handling warning letters and comprehensive bans, but there is a lack of a team responsible for enforcing fines and sales bans. Former FDA Center for Tobacco Products Director Mitch Zeller stated that this move essentially allows retailers to "flout the law," severely undermining policies aimed at controlling youth tobacco use.

 

In 2024, the tobacco use rate among American teenagers hit a new low in 25 years, causing concern among health experts. They worry that without continued federal enforcement support, this achievement could face the risk of reversal. At the same time, the Civil Monetary Penalty Office is also a key tool in combating the illegal distribution of e-cigarettes.

 

Currently, it is not clear why the Department of Health and Human Services (HHS) is focusing on dismantling the office responsible for civil penalties, which is a part of the U.S. Food and Drug Administration's (FDA) tobacco enforcement system known as the Division of Business Operations. The entire operational costs of the FDA Center for Tobacco Products are covered by user fees paid by the industry, with no involvement of federal budgets. This means that layoffs will not result in any savings for taxpayers, but could potentially reduce the Treasury's revenue from fines imposed by the FDA.

 

After layoffs, the FDA has not yet announced its future plan for enforcement restructuring. According to internal sources, some senior officials at the FDA's Center for Tobacco Products are still trying to fully restore its functions, but some employees have been told that returning to work in the short term does not necessarily mean they will be rehired in the future.

 

Department of Health and Human Services spokesperson Andrew Nixon stated in a declaration that laid-off employees may be required to work for a short period before their official departure date (June 2nd), with the aim of "minimizing disruptions to agency functions and ensuring a smooth transition.

 

Kennedy stated in a previous interview with the media that all positions that were cut were either administrative or considered redundant. He emphasized that the relevant work would be taken over by other programs through integration. Internal officials at the FDA have stated that these cuts have effectively paralyzed their tobacco enforcement actions. The agency's enforcement process consists of three stages: first-time offenders receive a warning letter, repeated violations result in civil penalties, and the most serious violations lead to a ban on all tobacco sales.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

UK HMRC Plans 30,000 Retail Enforcement Actions as Illegal Tobacco and Vape Sellers Face Tougher Crackdown
UK HMRC Plans 30,000 Retail Enforcement Actions as Illegal Tobacco and Vape Sellers Face Tougher Crackdown
The UK government has announced that HM Revenue & Customs (HMRC) will carry out more than 30,000 interventions targeting businesses and retail premises during the 2026-2027 financial year. The actions will focus on tax fraud, illegal goods sales and businesses involved in unlawful activities through retail channels. The government said illegal tobacco and illegal vape sales remain areas of concern. The move shows that UK enforcement against illegal nicotine products is expanding from import and supply channels toward retail-level oversight, alongside the upcoming introduction of the Vaping Products Duty.
Jul.24
France Vape Market 2026: Use Reaches 7.9% Amid Tax, Regulatory and Scientific Debate
France Vape Market 2026: Use Reaches 7.9% Amid Tax, Regulatory and Scientific Debate
France remains one of Europe’s active vape markets in 2026, with adult vaping prevalence rising to 7.9%; at the same time, e-liquid taxation, public-space restrictions, advertising compliance and health-risk debate are pushing the industry into a critical policy period.
Jun.23
Special Report | Russia, Ukraine and Belarus Launch Fresh Push to Rein in Vaping
Special Report | Russia, Ukraine and Belarus Launch Fresh Push to Rein in Vaping
Russia, Ukraine and Belarus are tightening vape regulation through different tools, from Ukraine’s stronger enforcement push and Belarus’s proposed advertising restrictions to Russia’s new GOST standard and regional sales-ban mechanism. As black-market concerns persist, some Russian experts argue that China’s tightly controlled but legalised model — built around licensing, traceability and taxation — may offer a more effective alternative to blanket prohibition.
Jul.15
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts held its 2026 U.S. Market Compliance and Development Mid-Year Briefing in Shenzhen, China, on July 28. The discussion examined how state-level requirements, proposed foreign-establishment registration rules and expanding supply-chain responsibilities are changing product and investment decisions in the U.S. tobacco and nicotine market.
Jul.29
PMI to Launch IQOS in Argentina by End-2026 After Regulatory Shift, Targeting About 7 Million Smokers
PMI to Launch IQOS in Argentina by End-2026 After Regulatory Shift, Targeting About 7 Million Smokers
Philip Morris International (PMI) has confirmed plans to bring its IQOS heated tobacco device to Argentina by the end of 2026, after the Argentine government lifted long-standing restrictions and created a regulatory framework for heated tobacco, e-cigarettes and nicotine pouches.
News
Jun.26 by 2Firsts Perspectives